| KAT # | Produkt Namme | Beskriuwing |
| CPD100391 | SHP394 | |
| CPD100390 | SHP389 (fergees basis) | |
| CPD3242 | RMC-4550 | RMC-4550 is in krêftige en selektive SHP2-ynhibitor. RMC-4550 identifisearre as in arkferbining fan hege kwaliteit om de rol fan SHP2 te studearjen yn tumorbiology, sawol in vitro as in vivo yn knaagdieren. SHP2 is in konvergente sinjaalknooppunt en remming fan SHP2 is effektyf yn it rjochtsjen fan sawol streamop (RTK-oandreaune) as streamôfwerts (RAS-GTP ôfhinklik) mutaasjes yn it RAS-MAPK paad |
- English
- Chinese
- French
- German
- Portuguese
- Spanish
- Russian
- Japanese
- Korean
- Arabic
- Irish
- Greek
- Turkish
- Italian
- Danish
- Romanian
- Indonesian
- Czech
- Afrikaans
- Swedish
- Polish
- Basque
- Catalan
- Esperanto
- Hindi
- Lao
- Albanian
- Amharic
- Armenian
- Azerbaijani
- Belarusian
- Bengali
- Bosnian
- Bulgarian
- Cebuano
- Chichewa
- Corsican
- Croatian
- Dutch
- Estonian
- Filipino
- Finnish
- Frisian
- Galician
- Georgian
- Gujarati
- Haitian
- Hausa
- Hawaiian
- Hebrew
- Hmong
- Hungarian
- Icelandic
- Igbo
- Javanese
- Kannada
- Kazakh
- Khmer
- Kurdish
- Kyrgyz
- Latin
- Latvian
- Lithuanian
- Luxembou..
- Macedonian
- Malagasy
- Malay
- Malayalam
- Maltese
- Maori
- Marathi
- Mongolian
- Burmese
- Nepali
- Norwegian
- Pashto
- Persian
- Punjabi
- Serbian
- Sesotho
- Sinhala
- Slovak
- Slovenian
- Somali
- Samoan
- Scots Gaelic
- Shona
- Sindhi
- Sundanese
- Swahili
- Tajik
- Tamil
- Telugu
- Thai
- Ukrainian
- Urdu
- Uzbek
- Vietnamese
- Welsh
- Xhosa
- Yiddish
- Yoruba
- Zulu
- Kinyarwanda
- Tatar
- Oriya
- Turkmen
- Uyghur